DXCM rates highest in P/B Growth Investor model, meeting various criteria.

From Nasdaq: 2024-08-10 13:18:53

Validea’s guru fundamental report for DEXCOM INC (DXCM) shows it rates highest in the P/B Growth Investor model, developed by Partha Mohanram. DXCM is a large-cap growth stock in the Medical Equipment & Supplies industry, with a rating of 88%. The strategy looks for low book-to-market stocks with sustained growth potential. The stock meets several criteria laid out by the strategy, including Return on Assets, Cash Flow from Operations to Assets, and Advertising to Assets, among others. Partha Mohanram is a renowned academic whose research has influenced investing strategies. Validea is an investment research service that follows strategies of investment legends.



Read more at Nasdaq: DXCM Quantitative Stock Analysis | Nasdaq